Clearside Biomedical, Inc. Announces Appointment of Richard J. Croarkin to the Board of Directors

ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical, a late-stage clinical biopharmaceutical company developing first-in-class drug therapies for the eye, announces that Richard J. Croarkin is joining its Board of Directors.